China invests $177 million in partnership with Insilico
China Medical System will pay up to $177 million to Insilico for research on the nervous system.
Published 21h1 sourceNotableupdated 18h
Lire en français
≈ 17s
The fact
The deal focuses on developing innovative treatments for neurodegenerative diseases.
This partnership highlights China's ambition in pharmaceutical biotechnology.